Clinical Trial Update: A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 dose-finding study evaluated MAL and HAL photodynamic therapy for cervical dysplasia, a cervical premalignant condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dysplasia

Drugs mentioned

• HAL (hexaminolevulinate)
• MAL (methyl aminolevulinate)

Snippet

Sponsor: Photocure | Conditions: Cervical Dysplasia | Phase 1, Phase 2 | Status: COMPLETED